Meridian Bioscience
VIVO
$33.97
Share price
0.00%
Change (1 day)
24.02%
Change (1 year)
Categories
Meridian Bioscience (VIVO) - Total debt
Total debt on the balance sheet as of September 2022 : $30.95 M
According to Meridian Bioscience's latest financial reports the company's total debt is $30.95 M. A company’s total debt is the sum of all current and non-current debts.
Meridian Bioscience - Total debt on balance sheet (from 2001 to 2022)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-09-30 | $30.95 M | -53.04% |
| 2021-09-30 | $65.92 M | -12.44% |
| 2020-09-30 | $75.29 M | -0.7% |
| 2019-09-30 | $75.82 M | 51.1% |
| 2018-09-30 | $50.18 M | -8.17% |
| 2017-09-30 | $54.64 M | -6.36% |
| 2016-09-30 | $58.36 M | |
| 2006-09-30 | $1.8 M | -44.35% |
| 2005-09-30 | $3.24 M | -81.79% |
| 2004-09-30 | $17.78 M | -22.14% |
| 2003-09-30 | $22.84 M | -16.96% |
| 2002-09-30 | $27.51 M | -14.99% |
| 2001-09-30 | $32.36 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $34.91 B | 112,691.94% | 🇺🇸 USA |
 Becton Dickinson BDX | $16.11 B | 51,939.93% | 🇺🇸 USA |
 Hologic HOLX | $2.57 B | 8,227.68% | 🇺🇸 USA |
 QuidelOrtho QDEL | $2.61 B | 8,344.29% | 🇺🇸 USA |